Both in Pharmaceuticals
Xeris Biopharma Holdings vs Harmony Biosciences Holdings
Over the past year XERS returned +19.7% and HRMY returned +37.2%; their daily moves had a correlation of 0.19.
XERS +19.7% HRMY +37.2%Growth of $1, one year, split-adjusted
| Metric | XERS | HRMY |
|---|---|---|
| Price | $10.86 | $36.03 |
| Market cap | $1.98B | $2.10B |
| Today | +0.70% | −5.95% |
| 1 month | +25.4% | −11.0% |
| 6 months | +82.5% | +12.3% |
| Year to date | +38.3% | −3.7% |
| 1 year | +19.6% | +37.7% |
| Revenue growth (YoY) | +28.7% | +30.3% |
| Gross margin | 86.4% | 75.8% |
| Net margin | −33.8% | 28.9% |
| P/E (TTM) | — | 11.6× |
| Price / sales | 5.9× | 2.2× |
| Net cash | -$130.8M | $513.8M |
| Dividend yield | — | — |
| Volatility (60d) | 55.9% | 36.5% |
| Short % of float | 4.1% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).